🇺🇸 FDA
Pipeline program

piclidenoson

CF101-302PS

Phase 3 small_molecule active

Quick answer

piclidenoson for Plaque Psoriasis is a Phase 3 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Can-Fite BioPharma
Indication
Plaque Psoriasis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials